12-187
Showing 26 - 50 of >10,000
Colorectal Cancer Metastatic Trial in Worldwide (TheraSphere)
Completed
- Colorectal Cancer Metastatic
- TheraSphere
-
Birmingham, Alabama
- +130 more
Mar 3, 2022
Posterior Malleolus Fractures, Ankle Fractures, Syndesmotic Injuries Trial (Fixation of the posterior malleolus fractures,
Not yet recruiting
- Posterior Malleolus Fractures
- +4 more
- Fixation of the posterior malleolus fractures
- +2 more
- (no location specified)
Jan 23, 2023
Urothelial Cancer Trial in Beijing (Atezolizumab, RO7247669, Tiragolumab)
Recruiting
- Urothelial Cancer
- Atezolizumab
- +2 more
-
Beijing, ChinaBeijing Cancer Hospital
Jan 18, 2023
E.Coli Infections, Bloodstream Infection Trial in Cincinnati (SNIPR001, Placebo)
Active, not recruiting
- E.Coli Infections
- Bloodstream Infection
- SNIPR001
- Placebo
-
Cincinnati, OhioMedpace Clinical Pharmacology
Dec 1, 2022
Fatigue, Breast Cancer Trial in Italy (APPOPRTAL®, Placebo)
Not yet recruiting
- Fatigue
- Breast Cancer
- APPOPRTAL®
- Placebo
-
Rozzano, Milano, Italy
- +6 more
Nov 14, 2023
Dengue Fever, Dengue Hemorrhagic Fever Trial in Worldwide (CYD Dengue Vaccine (5-dose formulation), Placebo, NaCl 0.9%)
Completed
- Dengue Fever
- Dengue Hemorrhagic Fever
- CYD Dengue Vaccine (5-dose formulation)
- Placebo, NaCl 0.9%
-
Vitoria, Brazil
- +4 more
Mar 15, 2022
Skin Cancer, Non-Melanoma Trial (HIFU)
Completed
- Skin Cancer, Non-Melanoma
- HIFU
-
Assiut, EgyptAssiut University
Nov 21, 2022
Skin Conductance Algesimeter and Nociception Level Index in
Not yet recruiting
- Nociceptive Pain
- +2 more
- Connecting patients to both non-invasive monitors to observe and compare the monitor's capabilities.
-
Nijmegen, Gelderland, NetherlandsRadboudumc
Aug 9, 2023
Asthma Trial (mometasone furoate/formoterol fumarate combination MDI 200/10 mcg BID, Mometasone furoate MDI (MF MDI) 200 mcg,
Completed
- Asthma
- mometasone furoate/formoterol fumarate combination MDI 200/10 mcg BID
- +3 more
- (no location specified)
Feb 7, 2022
Zika Virus Infection Trial in Vienna (Two MV-ZIKA-RSP vaccinations (high dose), Two MV-ZIKA-RSP vaccination (low dose), One
Completed
- Zika Virus Infection
- Two MV-ZIKA-RSP vaccinations (high dose)
- +3 more
-
Vienna, AustriaInstitute of Specific Prophylaxis and Tropical Medicine
Oct 28, 2021
Walking Impairment, Multiple Sclerosis Trial in Canada, United States (ADS-5102, 137 mg, ADS-5102, 274 mg, Placebo)
Completed
- Walking Impairment
- Multiple Sclerosis
- ADS-5102, 137 mg
- +2 more
-
Cullman, Alabama
- +83 more
Dec 19, 2021
Community-dwelling Older Adults Trial in Évora (Multimodal exercise program)
Suspended
- Community-dwelling Older Adults
- Multimodal exercise program
-
Évora, PortugalUniversidade de Évora
May 16, 2022
Bulimia Nervosa Trial in Heidelberg (Selfapy for Bulimia Nervosa)
Recruiting
- Bulimia Nervosa
- Selfapy for Bulimia Nervosa
-
Heidelberg, Baden-Württemberg, GermanyHeidelberg University
May 16, 2022
Birth Weight-discordance in Twins Pregnancy:Multicenter
Completed
- Twin; Pregnancy, Affecting Fetus or Newborn
-
Guangzhou, Guangdong, ChinaBijun Shi
Jan 6, 2023
Nicotine Dependence, Cigarettes Trial in Burlington (Nicotine Corrective Messages)
Completed
- Nicotine Dependence, Cigarettes
- Nicotine Corrective Messages
-
Burlington, VermontUniversity of Vermont
Nov 15, 2022
Smoking Cessation, HIV Trial in Miami (Combination Therapy, Standard Care Intervention)
Completed
- Smoking Cessation
- HIV
- Combination Therapy
- Standard Care Intervention
-
Miami, FloridaUniversity of Miami
Oct 4, 2021
COPD Trial in Bedford, Boston (VC-OPTIONS)
Not yet recruiting
- Chronic Obstructive Pulmonary Disease
- VC-OPTIONS
-
Bedford, Massachusetts
- +1 more
Aug 9, 2023
Hepatocellular Carcinoma Trial (Ezurpimtrostat, Atezolizumab, Bevacizumab)
Recruiting
- Hepatocellular Carcinoma
- Ezurpimtrostat
- +2 more
-
Grenoble, FranceUniversity Hospital
Dec 23, 2022
Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive Trial in Tokyo (OCH-NCNP1, Placebo)
Active, not recruiting
- Multiple Sclerosis, Relapsing-Remitting
- Multiple Sclerosis, Secondary Progressive
- OCH-NCNP1
- Placebo
-
Tokyo, JapanNational Center of Neurology and Psychiatry
Sep 28, 2022
Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, JNJ-64300535, ETV monohydrate)
Active, not recruiting
- Hepatitis B, Chronic
- JNJ-73763989
- +4 more
-
Edegem, Belgium
- +12 more
Jan 17, 2023
Overactive Bladder Syndrome Trial run by the (Vaginal estrogen, Mirabegron 50 MG [Myrbetriq])
Recruiting
- Overactive Bladder Syndrome
- Vaginal estrogen
- Mirabegron 50 MG [Myrbetriq]
-
Bethesda, MarylandWalter Reed National Military Medical Center
Nov 3, 2022
Ulcerative Colitis Trial in Japan (Etrasimod, Placebo)
Active, not recruiting
- Ulcerative Colitis
- Etrasimod
- Placebo
-
Nagoya-shi, Aichi, Japan
- +29 more
Dec 8, 2021
Chest Pain Trial (Point-of-Care Echocardiogram)
Not yet recruiting
- Chest Pain
- Point-of-Care Echocardiogram
- (no location specified)
Mar 23, 2023